Washington DC: Analysts for a recent study have developed a pioneering technique that has shown differences between immune cells in tumors, which could accelerate the development of cancer treatment.
Researchers at the University of Edinburgh analyzed gene from anonymous medical databases to thousands of tumors to identify immune cell-related genes. The findings of the study were published in the Journal of Cancer Immunology Study.
Scientists have said that the approach could be used to help doctors select the best treatment for individual patients and predict which tumors are likely to respond to a particular therapy.
It could also help focus the use of immunotherapy – a new form of treatment that uses physical defense to combat cancer. This therapy has shown a great promise in recent years, but finding out which patients will best respond is a challenge for doctors.
The new approach – based on gene analysis – is easier to detect the extent of immune cells present in the tumor. These cells could help the body discover and kill cancer when it is activated by some drugs, scientists say.
Traditional forms of treatment such as radiology do not differentiate between cell types and attack cancerous and healthy cells, which often lead to adverse effects.
The source called ImSig – the color best picture of tumors to date and will allow scientists to examine how certain types of immune cells affect cancer growth.